U.S. Markets closed

Merck&Co Earnings, Revenue Beat in Q2


Merck&Co Earnings, Revenue Beat in Q2

Investing.com - Merck&Co (NYSE:MRK) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $1.3 on revenue of $11.76B. Analysts polled by Investing.com anticipated EPS of $1.16 on revenue of $10.95B. That compared to EPS of $1.06 on revenue of $10.47B in the same period a year earlier. The company had reported EPS of $1.22 on revenue of $10.82B in the previous quarter.


Merck&Co follows other major Healthcare sector earnings this month


On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.

Novartis ADR earnings beat analysts' expectations on July 18, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Merck profit surges on strong sales of Keytruda, vaccines

Incyte Earnings, Revenue Beat in Q2

Sirius XM Earnings, Revenue Beat in Q2